Annual report pursuant to Section 13 and 15(d)

NOTE 6: MARKETABLE SECURITIES

v3.19.1
NOTE 6: MARKETABLE SECURITIES
12 Months Ended
Dec. 31, 2018
Notes  
NOTE 6: MARKETABLE SECURITIES

NOTE 6: MARKETABLE SECURITIES

 

The Company utilizes FAS 115 “Accounting for Certain Investments in Debt and Equity Securities”. The Company received marketable securities, 10,300,000 fully paid ordinary unrestricted shares in Impression Healthcare Limited (Australian Company), traded on Australian Security Exchange by the code IHL as part of the agreement and letter of intent (LOI). The Company categorize these securities as trading securities and report them at fair value, with unrealized gains and losses included in earnings. The Company recorded securities at FMV at the price of A$0.02 per share and exchange rate of $0.74 AUD/USD valued $150,000. On December 31, 2018 the stock price was A$ 0.02 per share as quoted on asx.com.au and exchange rate of $0.71 AUD/USD as quoted on olanda.com. The FMV change in marketable security was immaterial for the year ended December 31, 2018.